 this information to rationally develop in vivo models for examining the influence of FGF-retargeting on viral toxicity and immunogenicity, and for the development other ligand-viral conjugates. The data generated will validate the use of growth factor retargeting for gene therapy, and establish the groundwork required for its use in
this information to rationally develop in vivo models for examining the influence of FGF - retargeting on viral perniciousness and immunogenicity, and for the growth other ligand - viral conjugates. The datum generated will validate the manipulation of growth factor retargeting for gene therapy, and prove the groundwork required for its function in
 thls information to rationxlly develop in vivo mmdels ror examkning the influence of FGF-revargwting on viral toxicity and immunogejicity, abd fie the development other mlgand-rical conjugates. Jhe data genarated will vaniaace the use of growth factor retargetyng for gfne therapy, anq esuabjish nht groundwork required for its use in
this information to rationally develop in vivo examining influence of on viral toxicity development ligand-viral conjugates. The generated will validate use of growth factor retargeting for therapy, and establish the groundwork required for its use in
 this information to rationalLy develop iN vivo ModEls FoR exaMiniNg the influence OF FGF-Retargeting on viral toxiCity aNd IMmunOGeNicitY, and for THe DEVelOpMeNt oThER lIgand-VirAl conjuGates. The daTa gEnErated will vaLIdAte the use oF grOwth factor reTarGeting FoR geNE therApy, And esTablisH The groUndwork reQuIRed for ITs use in
 this information to ratio nally deve lop i n v ivo  m odel s fo r examining th e  inf luence of FGF-retarget ing o nv iral to xicit y and i m mu n o gen ic it y,an d  f or th e d evelopm ent otherlig an d-viral conj u ga tes. The d ata  generated w ill  valid at e t h e use  of  grow th fac t or ret argetingfo r  genet herapy, a nd  est ablish the ground w or k  required forits us ei n
 this_information to_rationally develop in vivo_models for_examining_the influence_of_FGF-retargeting on viral_toxicity and immunogenicity,_and for the development_other ligand-viral conjugates._The_data generated will validate the use of growth factor retargeting for gene therapy, and_establish_the groundwork_required_for_its use in